alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/Pressure_modification_or_humidification_for_improving_usage_of_continuous_positive_airway_pressure_machines_in_adults_with_obstructive_sleep_apnoea_New_search_for_studies_and_content_updated__conclusions_changed_.
Alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/Pressure_modification_or_humidification_for_improving_usage_of_continuous_positive_airway_pressure_machines_in_adults_with_obstructive_sleep_apnoea_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed February 13, 2025.
Alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/Pressure_modification_or_humidification_for_improving_usage_of_continuous_positive_airway_pressure_machines_in_adults_with_obstructive_sleep_apnoea_New_search_for_studies_and_content_updated__conclusions_changed_
Alemtuzumab Versus Interferon Beta 1a for Relapsing‐remitting Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/Pressure_modification_or_humidification_for_improving_usage_of_continuous_positive_airway_pressure_machines_in_adults_with_obstructive_sleep_apnoea_New_search_for_studies_and_content_updated__conclusions_changed_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
ID - 432006
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432006/all/Pressure_modification_or_humidification_for_improving_usage_of_continuous_positive_airway_pressure_machines_in_adults_with_obstructive_sleep_apnoea_New_search_for_studies_and_content_updated__conclusions_changed_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -